Hutch News

Hutch News

Stories tagged 'Transplant and Immunotherapy'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 18, 2018

Three young international investigators working in metastatic breast cancer research at Fred Hutchinson Cancer Research Center recently received postdoctoral fellowships totaling nearly $500,000 — and more good news at Fred Hutch.

View story >


How the immune system’s key organ regenerates itself

Watch: Hutch researcher discusses harnessing the thymus’s knack for self-repair to boost immune function and help patients

Jan. 12, 2018 | By Susan Keown (text) and Robert Hood (video) / Fred Hutch News Service

Dr. Jarrod Dudakov's discoveries about thymus regeneration could lead to new therapies to improve immune system function in old age and make immunotherapies more effective.

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Fred Hutch has entered into a new partnership with Leidos Biomed for the Frederick National Laboratory for Cancer Research that aims to increase access to lifesaving stem-cell transplants for those who don’t have a tissue-matched, related donor. If successful, the collaboration could improve current methods of donor selection and make stem-cell transplants more readily available for those with leukemia, multiple myeloma and other blood disorders.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Fred Hutch/SCCA transplant patient survival above the expected rate in U.S.

For 5th year in a row, bone marrow transplant program receives top recognition

Dec. 22, 2017 | By Molly McElroy

For the fifth year in a row, the Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance has been recognized by the Center for International Blood and Marrow Transplant Research as exceeding expectations for one-year survival rates. These survival rates specifically pertain to patients who have received transplants of blood-forming stem cells from healthy donors, a procedure pioneered at Fred Hutch.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.